40
Participants
Start Date
December 31, 2002
Primary Completion Date
February 28, 2006
Study Completion Date
February 28, 2006
Ziprasidone
20mg pills, dosing will be flexible, ranging from 10 to 160 mg divided BID or TID for the duration of the 52 week trial. In very rare cases, if the subject has shown some benefit and no side effects at a dose of 160mg and the treating clinician feels a further dose increase is necessary, the case would need to be presented to all of the other Principal Investigators for special consideration of further dose increases in 20 mg increments to an absolute maximal dose of 220mg.
University of North Carolina, Chapel Hill, Chapel Hill
Case Western Reserve University, Cleveland
University of Washington, Seattle
Harvard University, Medford
Collaborators (1)
Pfizer
INDUSTRY
National Institute of Mental Health (NIMH)
NIH
University of North Carolina, Chapel Hill
OTHER